Toxicological consequences of extracellular hemoglobin: Biochemical and physiological perspectives

Antioxidants and Redox Signaling

Volumn 12, Issue 2, 2010, Pages 275-291

  Buehler, Paul W ^a   D'Agnillo, Felice ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; AZACITIDINE; BUTYRIC ACID DERIVATIVE; CD163 ANTIGEN; CORTICOSTEROID; HAPTOGLOBIN; HEMOGLOBIN; HYDROXYUREA; NITRIC OXIDE; PHOSPHODIESTERASE V INHIBITOR; SODIUM NITRITE; HYDROGEN PEROXIDE;

ANTIOXIDANT ACTIVITY; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD TOXICITY; BLOOD TRANSFUSION; CARDIOVASCULAR SYSTEM; CELL AGING; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CYTOTOXICITY; ENDOTHELIUM CELL; ERYTHROCYTE; HEMODYNAMICS; HEMOLYSIS; HUMAN; KIDNEY FAILURE; MACROPHAGE; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MONOCYTE; NONHUMAN; OXIDATION; PHAGOCYTOSIS; PLASMA; PRIORITY JOURNAL; PROTEIN BINDING; PULMONARY HYPERTENSION; RENOVASCULAR DISEASE; RESPIRATORY SYSTEM; RETICULOENDOTHELIAL SYSTEM; REVIEW; SICKLE CELL ANEMIA; ANIMAL; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

ANIMALS; ENDOTHELIAL CELLS; ERYTHROCYTES; HEMOGLOBINS; HEMOLYSIS; HUMANS; HYDROGEN PEROXIDE; OXIDATION-REDUCTION;

EID: 77949513218     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.2799     Document Type: Review

References (159)

1. Alayash AI. Oxygen therapeutics: Can we tame haemoglobin? Nat Rev Drug Discov 3: 152-159, 2004. (Pubitemid 38239776)
2. Amberson WR, Jennings JJ, and Rhode CM. Clinical experience with hemoglobin-saline solutions. J Appl Physiol 1: 469-489, 1949.
3. Asleh R, Blum S, Kalet-Litman S, Alshiek J, Miller-Lotan R, Asaf R, Rock W, Aviram M, Milman U, Shapira C, Abassi Z, and Levy AP. Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype. Diabetes 57: 2794-2800, 2008.
4. Asleh R, Guetta J, Kalet-Litman S, Miller-Lotan R, and Levy AP. Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo. Circ Res 96: 435-441, 2005. (Pubitemid 40354537)
5. Asleh R, Miller-Lotan R, Aviram M, Hayek T, Yulish M, Levy JE, Miller B, Blum S, Milman U, Shapira C, and Levy AP. Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo. Circ Res 99: 1419-1425, 2006. (Pubitemid 44949678)
6. Atkinson SH, Rockett K, Sirugo G, Bejon PA, Fulford A, O'Connell MA, BaileyR,Kwiatkowski DP, and Prentice AM. Seasonal childhood anaemia in West Africa is associated with the haptoglobin 2-2 genotype. PLoS Med 3: e172, 2006.
7. Azarov I, He X, Jeffers A, Basu S, Ucer B, Hantgan RR, Levy A, and Kim-Shapiro DB. Rate of nitric oxide scavenging by hemoglobin bound to haptoglobin. Nitric Oxide 18: 296-302, 2008.
8. Balla G, Vercellotti GM, Muller-Eberhard U, Eaton J, and Jacob HS. Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab Invest 64: 648-655, 1991.
9. Balla J, Jacob HS, Balla G, Nath K, Eaton JW, and Vercellotti GM. Endothelial-cell heme uptake from heme proteins: Induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci USA 90: 9285-9289, 1993. (Pubitemid 23315768)
10. Balla J, Nath KA, Balla G, Juckett MB, Jacob HS, and Ver-cellotti GM. Endothelial cell heme oxygenase and ferritin induction in rat lung by hemoglobin in vivo. Am J Physiol 268: L321-327, 1995.
11. Balla J, Vercellotti GM, Jeney V, Yachie A, Varga Z, Jacob HS, Eaton JW, and Balla G. Heme, heme oxygenase, and ferritin: How the vascular endothelium survives (and dies) in an iron-rich environment. Antioxid Redox Signal 9: 2119-2137, 2007. (Pubitemid 350059014)
12. Balla J, Vercellotti GM, Nath K, Yachie A, Nagy E, Eaton JW, and Balla G. Haem, haem oxygenase and ferritin in vascular endothelial cell injury. Nephrol Dial Transplant 18 Suppl 5: v8-12, 2003.
13. Bayliss W. Is haemolysed blood toxic? Br J Exp Pathol 1: 1-8, 1920.
14. Behonick GS, Novak MJ, Nealley EW, and Baskin SI. Toxicology update: The cardiotoxicity of the oxidative stress metabolites of catecholamines (aminochromes). J Appl Tox-icol 21 Suppl 1: S15-22, 2001.
15. Belcher JD, Mahaseth H, Welch TE, Otterbein LE, Hebbel RP, and Vercellotti GM. Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. J Clin Invest 116: 808-816, 2006. (Pubitemid 43326890)
16. Belcher JD, Mahaseth H, Welch TE, Vilback AE, Sonbol KM, Kalambur VS, Bowlin PR, Bischof JC, Hebbel RP, and Vercellotti GM. Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice. Am J Physiol Heart Circ Physiol 288: H2715-2725, 2005. (Pubitemid 40720650)
17. Benvenisti-Zarom L and Regan RF. Astrocyte-specific heme oxygenase-1 hyperexpression attenuates heme-mediated oxidative injury. Neurobiol Dis 26: 688-695, 2007. (Pubitemid 46766635)
18. Beschorner R, Adjodah D, Schwab JM, Mittelbronn M, Pedal I, Mattern R, Schluesener HJ, and Meyermann R. Long-term expression of heme oxygenase-1 (HO-1, HSP-32) following focal cerebral infarctions and traumatic brain injury in humans. Acta Neuropathol 100: 377-384, 2000. (Pubitemid 30497006)
19. Bloch KD, Ichinose F, Roberts JD Jr, and Zapol WM. Inhaled NO as a therapeutic agent. Cardiovasc Res 75: 339-348, 2007. (Pubitemid 46961928)
20. Blum S, Asaf R, Guetta J, Miller-Lotan R, Asleh R, Kremer R, Levy NS, Berger FG, Aronson D, Fu X, Zhang R, Hazen SL, and Levy AP. Haptoglobin genotype determines myo-cardial infarct size in diabetic mice. J Am Coll Cardiol 49: 82-87, 2007. (Pubitemid 46026894)
21. Boretti FS, Buehler PW, D'Agnillo F, Kluge K, Glaus T, Butt OI, Jia Y, Goede J, Pereira CP, Maggiorini M, Schoedon G, Alayash AI, and Schaer DJ. Sequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and guinea pigs. J Clin Invest 119: 2271-2280, 2009.
22. Borsody M, Burke A, Coplin W, Miller-Lotan R, and Levy A. Haptoglobin and the development of cerebral artery vasospasm after subarachnoid hemorrhage. Neurology 66: 634-640, 2006. (Pubitemid 43739814)
23. Buehler PW, Abraham B, Vallelian F, Linnemayr C, Pereira CP, Cipollo JF, Jia Y, Mikolajczyk M, Boretti FS, Schoedon G, Alayash AI, and Schaer DJ. Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification. Blood 113: 2578-2586, 2009.
24. Buehler PW and Alayash AI. Toxicities of hemoglobin solutions: In search of in vitro and in vivo model systems. Transfusion 44: 1516-1530, 2004. (Pubitemid 39318989)
25. Bunn HF, Esham WT, and Bull RW. The renal handling of hemoglobin. I. Glomerular filtration. J Exp Med 129: 909-923, 1969.
26. Bunn HF and Jandl JH. The renal handling of hemoglobin. II. Catabolism. J Exp Med 129: 925-934, 1969.
27. Burhop K, Gordon D, and Estep T. Review of hemoglobin-induced myocardial lesions. Artif Cells Blood Substit Immobil Biotechnol 32: 353-374, 2004. (Pubitemid 39362756)
28. Cabrales P, Martini J, Intaglietta M, and Tsai AG. Blood viscosity maintains microvascular conditions during nor-movolemic anemia independent of blood oxygen-carrying capacity. Am J Physiol Heart Circ Physiol 291: H581-590, 2006. (Pubitemid 44175063)
29. Catalano CE, Choe YS, and Ortiz de Montellano PR. Reactions of the protein radical in peroxide-treated myoglo-bin. Formation of a heme-protein cross-link. J Biol Chem 264: 10534-10541, 1989. (Pubitemid 19161620)
30. Chaichana KL, Levy AP, Miller-Lotan R, Shakur S, and Tamargo RJ. Haptoglobin 2-2 genotype determines chronic vasospasm after experimental subarachnoid hemorrhage. Stroke 38: 3266-3271, 2007. (Pubitemid 350175747)
31. Chang JC, Lu R, Lin C, Xu SM, Kan YW, Porcu S, Carlson E, Kitamura M, Yang S, Flebbe-Rehwaldt L, and Gaensler KM. Transgenic knockout mice exclusively expressing human hemoglobin S after transfer of a 240-kb betas-globin yeast artificial chromosome: A mouse model of sickle cell anemia. Proc Natl Acad Sci USA 95: 14886-14890, 1998. (Pubitemid 29003726)
32. Cherry PD, Furchgott RF, Zawadzki JV, and Jothianandan D. Role of endothelial cells in relaxation of isolated arteries by bradykinin. Proc Natl Acad Sci USA 79: 2106-2110, 1982. (Pubitemid 12120806)
33. Cooper CE, Green ES, Rice-Evans CA, Davies MJ, and Wrigglesworth JM. A hydrogen-donating monohydroxa-mate scavenges ferryl myoglobin radicals. Free Radic Res 20: 219-227, 1994. (Pubitemid 24108510)
34. D'Agnillo F and Alayash AI. Interactions of hemoglobin with hydrogen peroxide alters thiol levels and course of endothelial cell death. Am J Physiol Heart Circ Physiol 279: H1880-1889, 2000.
35. D'Agnillo F and Alayash AI. Redox cycling of diaspirin cross-linked hemoglobin induces G2=M arrest and apoptosis in cultured endothelial cells. Blood 98: 3315-3323, 2001.
36. D'Agnillo F and Alayash AI. A role for the myoglobin re-dox cycle in the induction of endothelial cell apoptosis. Free Radic Biol Med 33: 1153-1164, 2002.
37. Damle SS, Moore EE, Babu AN, Meng X, Fullerton DA, and Banerjee A. Hemoglobin-based oxygen carrier induces heme oxygenase-1 in the heart and lung but not brain. J Am Coll Surg 208: 592-598, 2009.
38. De Castro LM, Jonassaint JC, Graham FL, Ashley-Koch A, and Telen MJ. Pulmonary hypertension associated with sickle cell disease: Clinical and laboratory endpoints and disease outcomes. Am J Hematol 83: 19-25, 2008.
39. de Figueiredo LF, Mathru M, Solanki D, Macdonald VW, Hess J, and Kramer GC. Pulmonary hypertension and systemic vasoconstriction may offset the benefits of acel-lular hemoglobin blood substitutes. J Trauma 42: 847-854; discussion 854-856, 1997.
40. Dejam A, Hunter CJ, Tremonti C, Pluta RM, Hon YY, Grimes G, Partovi K, Pelletier MM, Oldfield EH, Cannon RO, 3rd, Schechter AN, and Gladwin MT. Nitrite infusion in humans and nonhuman primates: Endocrine effects, pharmacokinetics, and tolerance formation. Circulation 116: 1821-1831, 2007. (Pubitemid 350287107)
41. Derchi G, Forni GL, Formisano F, Cappellini MD, Galanello R, D'Ascola G, Bina P, Magnano C, and Lamagna M. Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopa-thies. Haematologica 90: 452-458, 2005. (Pubitemid 40592887)
42. Dull RO, DeWitt BJ, Dinavahi R, Schwartz L, Hubert C, Pace N, and Fronticelli C. Quantitative assessment of hemoglobin-induced endothelial barrier dysfunction. J Appl Physiol 97: 1930-1937, 2004. (Pubitemid 39426013)
43. Eda K, Ohtsuka S, Seo Y, Yamada S, Ishiyama M, Miyamoto T, Horigome H, and Yamaguchi I. Conservative treatment of hemolytic complication following coil embo-lization in two adult cases of patent ductus arteriosus. Jpn Circ J 65: 834-836, 2001.
44. Fabry ME, Sengupta A, Suzuka SM, Costantini F, Rubin EM, Hofrichter J, Christoph G, Manci E, Culberson D, Factor SM, and Nagel RL. A second generation transgenic mouse model expressing both hemoglobinS(HbS) and HbS-Antilles results in increased phenotypic severity. Blood 86: 2419-2428, 1995.
45. Fagoonee S, Gburek J, Hirsch E, Marro S, Moestrup SK, Laurberg JM, Christensen EI, Silengo L, Altruda F, and Tolosano E. Plasma protein haptoglobin modulates renal iron loading. Am J Pathol 166: 973-983, 2005. (Pubitemid 40524423)
46. Ferreira AL, Matsubara LS, and Matsubara BB. Anthracycline-induced cardiotoxicity. Cardiovasc Hematol Agents Med Chem 6: 278-281, 2008.
47. Foresti R, Bains S, Sulc F, Farmer PJ, Green CJ, and Mot-terlini R. The interaction of nitric oxide with distinct hemoglobins differentially amplifies endothelial heme uptake and heme oxygenase-1 expression. J Pharmacol Exp Ther 317: 1125-1133, 2006. (Pubitemid 43764116)
48. Frostell C, Fratacci MD, Wain JC, Jones R, and Zapol WM. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83: 2038-2047, 1991.
49. Furchgott RF, Cherry PD, Zawadzki JV, and Jothianandan D. Endothelial cells as mediators of vasodilation of arteries. J Cardiovasc Pharmacol 6 Suppl 2: S336-343, 1984. (Pubitemid 14089107)
50. Furchgott RF and Zawadzki JV. The obligatory role of en-dothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980. (Pubitemid 11169009)
51. Gaasch JA, Geldenhuys WJ, Lockman PR, Allen DD, and Van der Schyf CJ. Voltage-gated calcium channels provide an alternate route for iron uptake in neuronal cell cultures. Neurochem Res 32: 1686-1693, 2007. (Pubitemid 47428848)
52. George I, Yi GH, Schulman AR, Morrow BT, Cheng Y, Gu A, Zhang G, Oz MC, Burkhoff D, and Wang J. A polymerized bovine hemoglobin oxygen carrier preserves regional myocardial function and reduces infarct size after acute myocardial ischemia. Am J Physiol Heart Circ Physiol 291: H1126-1137, 2006. (Pubitemid 44343656)
53. Gladwin MT, Lancaster JR, Jr., Freeman BA, and Schechter AN. Nitric oxide's reactions with hemoglobin: A view through the SNO-storm. Nat Med 9: 496-500, 2003. (Pubitemid 36597087)
54. Glover RE, Ivy ED, Orringer EP, Maeda H, and Mason RP. Detection of nitrosyl hemoglobin in venous blood in the treatment of sickle cell anemia with hydroxyurea. Mol Pharmacol 55: 1006-1010, 1999. (Pubitemid 29252365)
55. Gong Y, Hua Y, Keep RF, Hoff JT, and Xi G. Intracerebral hemorrhage: Effects of aging on brain edema and neurological deficits. Stroke 35: 2571-2575, 2004. (Pubitemid 39458419)
56. Gulati A, Barve A, and Sen AP. Pharmacology of hemoglobin therapeutics. J Lab Clin Med 133: 112-119, 1999. (Pubitemid 29073234)
57. Gulati A and Rebello S. Diaspirin cross-linked hemoglobin (DCLHB): Involvement of adrenergic mechanisms in the pressor effect. Artif Cells Blood Substit Immobil Biotechnol 22: 603-612, 1994. (Pubitemid 24252409)
58. Gulati A and Rebello S. Role of adrenergic mechanisms in the pressor effect of diaspirin cross-linked hemoglobin. J Lab Clin Med 124: 125-133, 1994.
59. Gulati A, Sen AP, Sharma AC, and Singh G. Role of ET and NO in resuscitative effect of diaspirin cross-linked hemoglobin after hemorrhage inrat. Am J Physiol 273: H827-836, 1997.
60. Gulati A and Sharma AC. Prazosin blocks the pressor but not the regional circulatory effects of diaspirin crosslinked hemoglobin. Life Sci 55: 121-130, 1994. (Pubitemid 24187108)
61. Gulati A, Sharma AC, and Singh G. Role of endothelin in the cardiovascular effects of diaspirin crosslinked and stroma reduced hemoglobin. Crit Care Med 24: 137-147, 1996.
62. Gulati A, Singh G, Rebello S, and Sharma AC. Effect of diaspirin crosslinked and stroma-reduced hemoglobin on mean arterial pressure and endothelin-1 concentration in rats. Life Sci 56: 1433-1442, 1995.
63. Hamilton P, Hiller A, and Van Slyke DD. Renal effects of hemoglobin infusions in dogs in hemorrhagic shock. J Exp Med 86: 477-487, 1947.
64. Hebbel RP. Auto-oxidation and a membrane-associated 'Fenton reagent': A possible explanation for development of membrane lesions in sickle erythrocytes. Clin Haematol 14: 129-140, 1985.
65. Hua Y, Keep RF, Hoff JT, and XiG. Deferoxamine therapy for intracerebral hemorrhage. Acta Neurochir Suppl 105: 3-6, 2008.
66. Huang FP, Xi G, Keep RF, Hua Y, Nemoianu A, and Hoff JT. Brain edema after experimental intracerebral hemorrhage: Role of hemoglobin degradation products. J Neuro-surg 96: 287-293, 2002. (Pubitemid 34230243)
67. Huang L, Wojciechowski G, and Ortiz de Montellano PR. Prosthetic heme modification during halide ion oxidation. Demonstration of chloride oxidation by horseradish per-oxidase. J Am Chem Soc 127: 5345-5353, 2005. (Pubitemid 40569846)
68. Huang L, Wojciechowski G, and Ortiz de Montellano PR. Role of heme-protein covalent bonds in mammalian per-oxidases. Protection of the heme by a single engineered heme-protein link in horseradish peroxidase. J Biol Chem 281: 18983-18988, 2006. (Pubitemid 44035401)
69. Jia Y, Buehler PW, Boykins RA, Venable RM, and Alayash AI. Structural basis of peroxide-mediated changes in human hemoglobin: A novel oxidative pathway. J Biol Chem 282: 4894-4907, 2007. (Pubitemid 47100947)
70. Johnson T, Arnaud F, Dong F, Philbin N, Rice J, Asher L, Arrisueno M, Warndorf M, Gurney J, McGwin G, Kaplan L, FlournoyWS, AppleFS, PearceLB,AhlersS,McCarronR,and Freilich D. Bovine polymerized hemoglobin (hemoglobin-based oxygen carrier-201) resuscitation in three swine models of hemorrhagic shock with militarily relevant delayed evacuation-Effects on histopathology and organ function. Crit Care Med 34: 1464-1474, 2006.
71. Koeppen AH, Dickson AC, and Smith J. Heme oxygenase in experimental intracerebral hemorrhage: The benefit of tin-mesoporphyrin. J Neuropathol Exp Neurol 63: 587-597, 2004. (Pubitemid 38736422)
72. Kolnagou A, Fessas C, Papatryphonas A, Economides C, and Kontoghiorghes GJ. Prophylactic use of deferiprone (L1) and magnetic resonance imaging T2* or T2 for preventing heart disease in thalassaemia. Br J Haematol 127: 360-361; author reply 361-362, 2004.
73. Kolnagou A, Michaelides Y, Kontos C, Kyriacou K, and Kontoghiorghes GJ. Myocyte damage and loss of myofibers is the potential mechanism of iron overload toxicity in congestive cardiac failure in thalassemia. Complete reversal of the cardiomyopathy and normalization of iron load by deferiprone. Hemoglobin 32: 17-28, 2008. (Pubitemid 351264514)
74. Kubulus D, Rensing H, Paxian M, Thierbach JT, Meisel T, Redl H, Bauer M, and Bauer I. Influence of heme-based solutions on stress protein expression and organ failure after hemorrhagic shock. Crit Care Med 33: 629-637, 2005. (Pubitemid 40365567)
75. Lara FA, Kahn SA, da Fonseca AC, Bahia CP, Pinho JP, Graca-Souza AV, Houzel JC, de Oliveira PL, Moura-Neto V, and Oliveira MF. On the fate of extracellular hemoglobin and heme in brain. J Cereb Blood Flow Metab 29: 1109-1120, 2009.
76. Levy AP, Levy JE, Kalet-Litman S, Miller-Lotan R, Levy NS, Asaf R, Guetta J, Yang C, Purushothaman KR, Fuster V, and Moreno PR. Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque. Arterioscler Thromb Vasc Biol 27: 134-140, 2007. (Pubitemid 46360390)
77. Levy AP and Moreno PR. Intraplaque hemorrhage. Curr Mol Med 6: 479-488, 2006.
78. Levy AP, Roguin A, Hochberg I, Herer P, Marsh S, Na-khoul FM, and Skorecki K. Haptoglobin phenotype and vascular complications in patients with diabetes. N Engl J Med 343: 969-970, 2000.
79. Levy NS and Levy AP. ELISA for determination of the haptoglobin phenotype. Clin Chem 50: 2148-2150, 2004. (Pubitemid 39425854)
80. Lim SK, Kim H, Lim SK, bin Ali A, Lim YK, Wang Y, Chong SM, Costantini F, and Baumman H. Increased susceptibility in Hp knockout mice during acute hemolysis. Blood 92: 1870-1877, 1998. (Pubitemid 28446675)
81. Lim YK, Jenner A, Ali AB, Wang Y, Hsu SI, Chong SM, Baumman H, Halliwell B, and Lim SK. Haptoglobin reduces renal oxidative DNA and tissue damage during phenylhydrazine-induced hemolysis. Kidney Int 58: 1033-1044, 2000.
82. Lin L. RAGE on the Toll Road? Cell Mol Immunol 3: 351-358, 2006.
83. Lin L, Park S, and Lakatta EG. RAGE signaling in inflammation and arterial aging. Front Biosci 14: 1403-1413, 2009.
84. Macdonald RL and Weir BK. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22: 971-982, 1991.
85. Matz P, Turner C, Weinstein PR, Massa SM, Panter SS, and Sharp FR. Heme-oxygenase-1 induction in glia throughout rat brain following experimental subarachnoid hemorrhage. Brain Res 713: 211-222, 1996. (Pubitemid 26114842)
86. Miller-Lotan R, Herskowitz Y, Kalet-Litman S, Nakhoul F, Aronson D, Zoabi R, Asaf R, Ben-Izhak O, Sabo E, Lim SK, Baumann H, Berger FG, and Levy AP. Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus. Diabetes Metab Res Rev 21: 332-337, 2005. (Pubitemid 40945954)
87. Miller-Lotan R, Miller B, Nakhoul F, Aronson D, Asaf R, and Levy AP. Retinal capillary basement membrane thickness in diabetic mice genetically modified at the haptoglobin locus. Diabetes Metab Res Rev 23: 152-156, 2007.
88. Minneci PC, Deans KJ, Shiva S, Zhi H, Banks SM, Kern S, Natanson C, Solomon SB, and Gladwin MT. Nitrite reduc-tase activity of hemoglobin as a systemic nitric oxide generator mechanism to detoxify plasma hemoglobin produced during hemolysis. Am J Physiol Heart Circ Physiol 295: H743- 754, 2008.
89. Minneci PC, Deans KJ, Zhi H, Yuen PS, Star RA, Banks SM, Schechter AN, Natanson C, Gladwin MT, and Solomon SB. Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompart-mentalized oxyhemoglobin. J Clin Invest 115: 3409-3417, 2005. (Pubitemid 43121829)
90. Morris CR, Morris SM, Jr., Hagar W, Van Warmerdam J, Claster S, Kepka-Lenhart D, Machado L, Kuypers FA, and Vichinsky EP. Arginine therapy: A new treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med 168: 63-69, 2003. (Pubitemid 37046634)
91. Motterlini R, Foresti R, Vandegriff K, Intaglietta M, and Winslow RM. Oxidative-stress response in vascular endo-thelial cells exposed to acellular hemoglobin solutions. Am J Physiol 269: H648-655, 1995.
92. Mullon J, Giacoppe G, Clagett C, McCune D, and Dillard T. Transfusions of polymerized bovine hemoglobin in a patient with severe autoimmune hemolytic anemia. N Engl J Med 342: 1638-1643, 2000. (Pubitemid 30341533)
93. Nagel RL and Fabry ME. The panoply of animal models for sickle cell anaemia. Br J Haematol 112: 19-25, 2001. (Pubitemid 32151143)
94. Naito Y, Nakajima M, Inoue H, and Tsuchiya K. Successful CABG in a patient with paroxysmal nocturnal hemoglo-binuria. Eur J Cardiothorac Surg 25: 468-470, 2004. (Pubitemid 38340593)
95. Nakamura T, Keep RF, Hua Y, Schallert T, Hoff JT, and Xi G. Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J Neurosurg 100: 672-678, 2004. (Pubitemid 38372849)
96. Nakhoul FM, Miller-Lotan R, Awad H, Asleh R, Jad K, Nakhoul N, Asaf R, Abu-Saleh N, and Levy AP. Pharma-cogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus. Am J Physiol Renal Physiol 296: F830-838, 2009.
97. Natanson C, Kern SJ, Lurie P, Banks SM, and Wolfe SM. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: A meta-analysis. JAMA 299: 2304-2312, 2008. (Pubitemid 351724397)
98. Nath KA. Heme oxygenase-1: A provenance for cytopro-tective pathways in the kidney and other tissues. Kidney Int 70: 432-443, 2006. (Pubitemid 44141569)
99. Nath KA. Preservation of the kidney by carbon monoxide: A black swan phenomenon. Kidney Int 74: 989-991, 2008.
100. Nath KA, Croatt AJ, Haggard JJ, and Grande JP. Renal response to repetitive exposure to heme proteins: Chronic injury induced by an acute insult. Kidney Int 57: 2423-2433, 2000. (Pubitemid 30340740)
101. Nath KA, Grande JP, Croatt AJ, Likely S, Hebbel RP, and Enright H. Intracellular targets in heme protein-induced renal injury. Kidney Int 53: 100-111, 1998. (Pubitemid 28066908)
102. Nath KA, Vercellotti GM, Grande JP, Miyoshi H, Paya CV, Manivel JC, Haggard JJ, Croatt AJ, Payne WD, and Alam J. Heme protein-induced chronic renal inflammation: Sup-pressive effect of induced heme oxygenase-1. Kidney Int 59: 106-117, 2001. (Pubitemid 32055219)
103. O'Rourke M. Mechanical principles in arterial disease. Hypertension 26: 2-9, 1995.
104. Ogihara K, Zubkov AY, Bernanke DH, Lewis AI, Parent AD, and Zhang JH. Oxyhemoglobin-induced apoptosis in cultured endothelial cells. J Neurosurg 91: 459-465, 1999. (Pubitemid 29404439)
105. Ohshiro TU, Mukai K, and Kosaki G. Prevention of he-moglobinuria by administration of haptoglobin. Res Exp Med (Berl) 177: 1-12, 1980.
106. Ono S, Komuro T, and Macdonald RL. Heme oxygenase-1 gene therapy for prevention of vasospasm in rats. J Neu-rosurg 96: 1094-1102, 2002. (Pubitemid 34579028)
107. Paller MS. Hemoglobin- and myoglobin-induced acute renal failure in rats: Role of iron in nephrotoxicity. Am J Physiol 255: F539-544, 1988.
108. Panter SS. Release of iron from hemoglobin. Methods En-zymol 231: 502-514, 1994. (Pubitemid 24169862)
109. Paszty C, Brion CM, Manci E, Witkowska HE, Stevens ME, Mohandas N, and Rubin EM. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science 278: 876-878, 1997. (Pubitemid 27467927)
110. Peacock AC, Gelderman AH, Ragland RH, and Hoffman HA. Haptoglobin levels in serum of various strains of mice. Science 158: 1703-1704, 1967.
111. Rabiner SF, Helbert JR, Lopas H, and Friedman LH. Evaluation of a stroma-free hemoglobin solution for use as a plasma expander. J Exp Med 126: 1127-1142, 1967.
112. Rabiner SF, O'Brien K, Peskin GW, and Friedman LH. Further studies with stroma-free hemoglobin solution. Ann Surg 171: 615-622, 1970.
113. Raghupathy R and Billett HH. Promising therapies in sickle cell disease. Cardiovasc Hematol Disord Drug Targets 9: 1-8, 2009.
114. Ramadas N and Rifkind JM. Molecular dynamics of human methemoglobin: The transmission of conformational information between subunitsinanalpha beta dimer. Biophys J 76: 1796-1811, 1999. (Pubitemid 29266338)
115. Reeder BJ, Cutruzzola F, Bigotti MG, Hider RC, and Wilson MT. Tyrosine as a redox-active center in electron transfer to ferryl heme in globins. Free Radic Biol Med 44: 274-283, 2008.
116. Reeder BJ, Cutruzzola F, Bigotti MG, Watmough NJ, and Wilson MT. Histidine and not tyrosine is required for the peroxide-induced formation of haem to protein cross-linked myoglobin. IUBMB Life 59: 477-489, 2007. (Pubitemid 47265846)
117. Reeder BJ, Grey M, Silaghi-Dumitrescu RL, Svistunenko DA, Bulow L, Cooper CE, and Wilson MT. Tyrosine residues as redox cofactors in human hemoglobin: Implications for engineering nontoxic blood substitutes. J Biol Chem 283: 30780-30787, 2008.
118. Reeder BJ, Hider RC, and Wilson MT. Iron chelators can protect against oxidative stress through ferryl heme reduction. Free Radic Biol Med 44: 264-273, 2008.
119. Reeder BJ, Sharpe MA, Kay AD, Kerr M, Moore K, and Wilson MT. Toxicity of myoglobin and haemoglobin: Oxidative stress in patients with rhabdomyolysis and sub-arachnoid haemorrhage. Biochem Soc Trans 30: 745-748, 2002. (Pubitemid 35001646)
120. Reeder BJ, Svistunenko DA, Cooper CE, and Wilson MT. The radical and redox chemistry of myoglobin and hemoglobin: From in vitro studies to human pathology. Antioxid Redox Signal 6: 954-966, 2004. (Pubitemid 39434932)
121. Regan RF, Chen J, and Benvenisti-Zarom L. Heme oxygenase-2 gene deletion attenuates oxidative stress in neurons exposed to extracellular hemin. BMC Neurosci 5: 34, 2004.
122. Regan RF, Guo Y, and Kumar N. Heme oxygenase-1 induction protects murine cortical astrocytes from hemoglobin toxicity. Neurosci Lett 282: 1-4, 2000. (Pubitemid 30129154)
123. Regan RF and Panter SS. Neurotoxicity of hemoglobin in cortical cell culture. Neurosci Lett 153: 219-222, 1993. (Pubitemid 23147074)
124. Regan RF and Panter SS. Hemoglobin potentiates ex-citotoxic injury in cortical cell culture. J Neurotrauma 13: 223-231, 1996. (Pubitemid 26142615)
125. Repka T and Hebbel RP. Hydroxyl radical formation by sickle erythrocyte membranes: Role of pathologic iron deposits and cytoplasmic reducing agents. Blood 78: 2753-2758, 1991.
126. Rother RP, Bell L, Hillmen P, and Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: A novel mechanism of human disease. JAMA 293: 1653-1662, 2005. (Pubitemid 40471796)
127. Ryan TM, Townes TM, Reilly MP, Asakura T, Palmiter RD, Brinster RL, and Behringer RR. Human sickle hemoglobin in transgenic mice. Science 247: 566-568, 1990.
128. Sadrzadeh SM, Anderson DK, Panter SS, Hallaway PE, and Eaton JW. Hemoglobin potentiates central nervous system damage. J Clin Invest 79: 662-664, 1987. (Pubitemid 17009711)
129. Savitsky JP, Doczi J, Black J, and Arnold JD. A clinical safety trial of stroma-free hemoglobin. Clin Pharmacol Ther 23: 73-80, 1978. (Pubitemid 8290413)
130. Schaer CA, Schoedon G,ImhofA, Kurrer MO, and Schaer DJ. Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages to hemoglobin. Circ Res 99: 943-950, 2006. (Pubitemid 44657797)
131. Schechter AN. Hemoglobin research and the origins of molecular medicine. Blood 112: 3927-3938, 2008.
132. Schechter AN and Gladwin MT. Hemoglobin and the para-crine and endocrine functions of nitric oxide. N Engl J Med 348: 1483-1485, 2003. (Pubitemid 36407180)
133. Schipper HM. Heme oxygenase-1: Transducer of pathological brain iron sequestration under oxidative stress. Ann NY Acad Sci 1012: 84-93, 2004. (Pubitemid 38453517)
134. Sharma AC and Gulati A. Yohimbine modulates diaspirin crosslinked hemoglobin-induced systemic hemodynamics and regional circulatory effects. Crit Care Med 23: 874-884, 1995.
135. Shor M, Boaz M, Gavish D, Wainshtein J, Matas Z, and Shargorodsky M. Relation of haptoglobin phenotype to early vascular changes in patients with diabetes mellitus. Am J Cardiol 100: 1767-1770, 2007. (Pubitemid 350234796)
136. Simoni J, Simoni G, Moeller JF, Tsikouris JP, and Wesson DE. Evaluation of angiotensin converting enzyme (ACE)-like activity of acellular hemoglobin. Artif Cells Blood Substit Immobil Biotechnol 35: 191-210, 2007. (Pubitemid 46514898)
137. Steinberg MH, Lu ZH, Barton FB, Terrin ML, Charache S, and Dover GJ. Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea. Blood 89: 1078-1088, 1997. (Pubitemid 27121303)
138. Steudel W, Hurford WE, and Zapol WM. Inhaled nitric oxide: Basic biology and clinical applications. Anesthesiology 91: 1090-1121, 1999. (Pubitemid 29466545)
139. Svistunenko DA, Wilson MT, and Cooper CE. Tryptophan or tyrosine? On the nature of the amino acid radical formed following hydrogen peroxide treatment of cytochrome c oxidase. Biochim Biophys Acta 1655: 372-380, 2004. (Pubitemid 38526201)
140. Tanaka K, Kanamori Y, Sato T, Kondo C, Katayama Y, Yada I, Yuasa H, and Kusagawa M. Administration of haptoglobin during cardiopulmonary bypass surgery. ASAIO Trans 37: M482-483, 1991.
141. Teng ZP, Chen J, Chau LY, Galunic N, and Regan RF. Adenoviral transfer of the heme oxygenase-1 gene protects striatal astrocytes from heme-mediated oxidative injury. Neurobiol Dis 17: 179-187, 2004. (Pubitemid 39345774)
142. Tolosano E, Fagoonee S, Garuti C, Valli L, Andrews NC, Altruda F, and Pietrangelo A. Haptoglobin modifies the hemochromatosis phenotype in mice. Blood 105: 3353-3355, 2005.
143. Tolosano E, Fagoonee S, Hirsch E, Berger FG, Baumann H, Silengo L, and Altruda F. Enhanced splenomegaly and severe liver inflammation in haptoglobin=hemopexin double-null mice after acute hemolysis. Blood 100: 4201-4208, 2002. (Pubitemid 35402055)
144. Tracz MJ, Alam J, and Nath KA. Physiology and patho-physiology of heme: Implications for kidney disease. J Am Soc Nephrol 18: 414-420, 2007. (Pubitemid 46193307)
145. Turner CP, Panter SS, and Sharp FR. Anti-oxidants prevent focal rat brain injury as assessed by induction of heat shock proteins (HSP70, HO-1=HSP32, HSP47) following sub-arachnoid injections of lysed blood. Brain Res Mol Brain Res 65: 87-102, 1999. (Pubitemid 29138682)
146. Vallelian F, Pimenova T, Pereira CP, Abraham B, Miko-lajczyk MG, Schoedon G, Zenobi R, Alayash AI, Buehler PW, and Schaer DJ. The reaction of hydrogen peroxide with hemoglobin induces extensive alpha-globin cross-linking and impairs the interaction of hemoglobin with endogenous scavenger pathways. Free Radic Biol Med 45: 1150-1158, 2008.
147. Vinchi F, Gastaldi S, Silengo L, Altruda F, and Tolosano E. Hemopexin prevents endothelial damage and liver congestion in a mouse model of heme overload. Am J Pathol 173: 289-99, 2008. (Pubitemid 351947975)
148. Vollaard NB, Reeder BJ, Shearman JP, Menu P, Wilson MT, and Cooper CE. A new sensitive assay reveals that hemoglobin is oxidatively modified in vivo. Free Radic Biol Med 39: 1216-1228, 2005. (Pubitemid 41408584)
149. Wang J and Dore S. Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage. Brain 130: 1643-1652, 2007. (Pubitemid 47355932)
150. Wicher KB and Fries E. Haptoglobin, a hemoglobin-binding plasma protein, is present in bony fish and mammals but not in frog and chicken. Proc Natl Acad Sci USA 103: 4168-4173, 2006.
151. Winslow RM. Targeted O2 delivery by low-p50 hemoglobin: a new basis for hemoglobin-based oxygen carriers. Artif Cells Blood Substit Immobil Biotechnol 33: 1-12, 2005. (Pubitemid 40315174)
152. Wojciechowski G, Huang L, and Ortiz de Montellano PR. Autocatalytic modification of the prosthetic heme of horseradish but not lactoperoxidase by thiocyanate oxidation products. A role for heme-protein covalent cross-linking. J Am Chem Soc 127: 15871-15879, 2005. (Pubitemid 41644007)
153. Yamazaki H,Ohta K, Tsukiji H, Toma T,Hashida Y, Ishizaki A, Saito T, Arai S, Koizumi S, and Yachie A. Corticosteroid enhances heme oxygenase-1 production by circulating monocytes byup-regulating hemoglobin scavenger receptor andamplifyingthereceptor-mediateduptakeofhemoglobin-haptoglobin complex. Biochem Biophys Res Commun 358: 506-512, 2007. (Pubitemid 46755734)
154. Yang F, Ghio AJ, Herbert DC, Weaker FJ, Walter CA, and Coalson JJ. Pulmonary expression of the human haptoglo-bin gene. Am J Respir Cell Mol Biol 23: 277-282, 2000.
155. Yoshioka T, Sugimoto T, Ukai T, and Oshiro T. Haptoglobin therapy for possible prevention of renal failure following thermal injury: A clinical study. J Trauma 25: 281-287, 1985. (Pubitemid 15057810)
156. Yu B, Raher MJ, Volpato GP, Bloch KD, Ichinose F, and Zapol WM. Inhaled nitric oxide enables artificial blood transfusion without hypertension. Circulation 117: 1982- 1990, 2008. (Pubitemid 351543474)
157. Zager RA and Gamelin LM. Pathogenetic mechanisms in experimental hemoglobinuric acute renal failure. Am J Phy-siol 256: F446-455, 1989.
158. Zhang Y, Qui Y, Zhu J, and Gao D. Pulmonary hypertension associated with autoimmune hemolytic anemia: A case report. Int J Cardiol 115: e1-2, 2007. (Pubitemid 44873034)
159. Zvi B and Levy AP. Haptoglobin phenotypes, which one is better and when? Clin Lab 52: 29-35, 2006. (Pubitemid 43245862)